Form 4: Aspira Women's Health Director, Jannie Herchuk, Reports Stock Transactions
SEC Form 4
Director Jannie Herchuk reports acquisition and disposal of Aspira Women's Health Inc. common stock on August 12, 2024.
Summary
- On August 12, 2024, Jannie Herchuk, a director of Aspira Women's Health Inc., reported transactions involving the company's common stock.
- Herchuk acquired 20,017 shares of common stock at $0.
- Following the transaction, Herchuk directly owns 48,752 shares of Aspira Women's Health Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The director's acquisition of shares could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of stock transaction (acquisition and disposal). |
| 08/12/2024 | Restricted stock unit vested in full. |
| 08/13/2024 | Date of signature on the Form 4. |
Keywords
Aspira Women's Health Inc., Director, Stock Transaction, Form 4, Beneficial Ownership, AWH, Herchuk
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.